Trademark Details For SILI PHARMA (Serial Number 87758484)

  •  Home
  •  Print
SILI PHARMA
4
10
9
0
Serial Number  United States - USPTO 87758484
Registration Number 5610117
Mark
SILI PHARMA
Filing Date Jan-17-2018
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
Attorney Name
TTAB
0



  • Disclaimer:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Aug-10-2012

First Use in Commerce: Aug-10-2012





Correspondences

NameJianmin Zhou
AddressLaw Offices of James Zhou 17700 Castleton St, Ste 583 City of Industry,CA 91748

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jan-20-2018NEW APPLICATION ENTERED   NWAPI
Jan-29-2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Apr-27-2018ASSIGNED TO EXAMINER   DOCKD
May-30-2018ASSIGNED TO EXAMINER   DOCKD
Jun-06-2018EXAMINERS AMENDMENT -WRITTEN   CNEAR
Jun-06-2018EXAMINERS AMENDMENT E-MAILED   GNEAF
Jun-06-2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Jun-06-2018EXAMINER'S AMENDMENT ENTERED   XAECI
Jun-06-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jun-26-2018WITHDRAWN FROM PUB - OG REVIEW QUERY   PBCRZ
Jul-17-2018WITHDRAWN FROM PUB - OG REVIEW QUERY   PBCRZ
Aug-15-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Sep-04-2018PUBLISHED FOR OPPOSITION   PUBOA
Sep-04-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Nov-20-2018REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-20-2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Nov-21-2023TEAS SECTION 8 RECEIVED   ES8RI
Jan-31-2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-31-2024REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
Jan-31-2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E